Current NDC auxiliary source row compounder:115

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72934-2395
Product Ndc: 72934-2395
Product Ndc Digits: 729342395
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Diooxia CReam
Proprietary Name Suffix: [empty]
Nonproprietary Name: 161021 CALCIPOTRIENE 0.005% / NIACINAMIDE 4%
Dosage Form Name: CREAM
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: SKNV
Establishment Name: SKNV
Establishment Fei: [empty]
Substance Name: NIACINAMIDE; CALCIPOTRIENE
Active Ingredients Info: 4 g/100 mL; .005 g/100 mL
History Active Ingredients Raw: NIACINAMIDE; CALCIPOTRIENE
History Active Ingredients Info Raw: 4 g/100 mL; .005 g/100 mL
History Dosage Raw: CREAM
Dea Schedule: [empty]
Package Ndc Raw: 72934-2395-2
Package Ndc: 72934-2395-2
Package Ndc Digits: 7293423952
Package Ndc11: 72934239502
Package Description: 30 mL in 1 BOTTLE, PUMP (72934-2395-2)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:115
Source Row Number: 115
Source Row Hash: 57ceec99833c6e07f78e3ca484d4fc70f68488d203ca334a92e18a725a70c3f8
Import Run Id: 20261020T105720Z
Loaded At: 2026-10-20 11:03:50

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "72934-2395",
    "DEASCHEDULE": "",
    "LABELERNAME": "SKNV",
    "SUBSTANCENAME": "NIACINAMIDE; CALCIPOTRIENE",
    "DOSAGEFORMNAME": "CREAM",
    "NDCPACKAGECODE": "72934-2395-2",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Diooxia CReam",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "161021 CALCIPOTRIENE 0.005% / NIACINAMIDE 4%",
    "PACKAGEDESCRIPTION": "30 mL in 1 BOTTLE, PUMP (72934-2395-2) ",
    "ACTIVEINGREDIENTSINFO": "4 g/100 mL; .005 g/100 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:115
Source Row Number: 115
Status Scope: package
Lookup Ndc: 72934-2395-2
Lookup Ndc Digits: 7293423952
Product Ndc: 72934-2395
Product Ndc Digits: 729342395
Package Ndc: 72934-2395-2
Package Ndc Digits: 7293423952
Package Ndc11: 72934239502
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 57ceec99833c6e07f78e3ca484d4fc70f68488d203ca334a92e18a725a70c3f8
Import Run Id: 20261020T105720Z
Loaded At: 2026-10-20 11:03:50